The US FDA has confirmed its commitment to creating an alternative route to market for non-pharmaceutical CBD products such as foods and dietary supplements – eventually ...
Recent studies show cannabinoids could help with sleep disorders, obsessive compulsive disorder (OCD), and cocaine addiction, while genetic research could help regulators delineate between cannabis strains ...
Despite eBay’s claims to the contrary, CBD products appear to remain very much obtainable through the online marketplace. But are they the real thing? ...
A meeting between the US FDA and members of the CBD industry provided the agency with plenty of information, but threw little light on the path it is likely to take ...
Payments company Square is studying the potential for providing financial services to the CBD sector, with an invite-only beta test currently under way ...
CBD continues to gain ground across sports in North America; with recent visibility in sports like rugby and baseball, and no general proscription against CBD use from the World Anti-Doping Code, it may be making...
Aurora Cannabis is to collaborate with Ultimate Fighting Championship (UFC), a mixed martial arts promotions company headquartered in Las Vegas, on studies of CBD’s possible usefulness in treating pain and inflammation and in recovery and...
Cannabinoid extracts require human intervention to change them from their natural state, a judge has ruled in a dispute that will help develop case law ...
The first in a new weekly round-up from around the US brings you news from Colorado, Florida, Indiana, Maine, New Jersey, New York, North Dakota, and Tennessee ...
CBD has taken off in US retail, with a number of major chains – including some unexpected ones – taking opportunities to cash in on the surging popularity of CBD products ...
Elavon Inc, a subsidiary of US Bank that processes card transactions, will cancel payment services for CBD businesses this week, documents seen by CBD-Intel reveal ...
The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis ...
Women are emerging as key players in the movement to promote medical CBD: starting their own businesses, campaigning for legalisation and creating networks for future empowerment ...
The US FDA is to hold a public hearing on 31st May on the safety of products containing cannabis or cannabis-derived compounds ― and stakeholders will be looking for a dividing line ...
Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be...
Social media influencers are the marketing medium of the moment, and the CBD market is especially well suited to cashing in on the fame and popularity of this new form of advertising ...
US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own...
CBD’s association with cannabis, on one level part of its marketing strength, can also be a big barrier to its acceptance. The major social networks all have as yet a rather ambiguous attitude ...
Proposed new federal legislation in the US could finally help CBD businesses gain easier access to banking, a problem that has bedevilled legal cannabis-related industries since their...
Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some...
A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded...
Ohio is moving a step nearer following its neighbour Michigan in distinguishing hemp-derived CBD products from state cannabis regulations, while Texas is to remove hemp from its list of controlled substances ...
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states...
Isodiol International, a large-scale CBD distributor based in Vancouver, Canada, has announced that it has acquired the brand and portfolio of California-based CBD Naturals ...
A series of year-end results from cannabis-related companies in the US demonstrates the importance of CBD to the bottom line, with volatility in much of the rest of the cannabis and pharmaceutical sectors ...
Obscure cannabinoids and even completely new ones could be produced synthetically from yeast, along with THC and CBD, according to scientists at the University of California in Berkeley ...
David Klein, the man who created the iconic Jelly Belly jelly bean in the 1970s, has entered the CBD edibles market with his latest start-up Spectrum Confections, established to make CBD jelly beans ...
North American businesses are still investing millions in the CBD hemp market, despite the uncertainty generated by new legislation and clampdowns on retailers, with many US and Canadian firms acquiring nascent businesses ...
A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders ...
The resignation of Food and Drug Administration (FDA) commissioner Scott Gottlieb adds further uncertainty to the future of federal oversight of CBD in the US ...
North American companies such as Canadian firms Tilray and SOL Global, and Chicago-based Cresco Labs, are all starting or expanding their cannabidiol interests ...
Several US states and territories are reporting changes to hemp policies following the passing of the 2018 US Farm Bill. One surprisingly positive example is Pennsylvania, which is backing growth ...
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan ...
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.